DE Stepan

643 total citations
9 papers, 503 citations indexed

About

DE Stepan is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, DE Stepan has authored 9 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in DE Stepan's work include Hematopoietic Stem Cell Transplantation (6 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). DE Stepan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Immunotherapy and Immune Responses (3 papers) and T-cell and B-cell Immunology (3 papers). DE Stepan collaborates with scholars based in United States. DE Stepan's co-authors include A. Molina, GM Schmidt, DS Snyder, EP Smith, PM Parker, MR O’Donnell, Auayporn Nademanee, AP Nademanee, George Somlo and Tucker W. LeBien and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bone Marrow Transplantation.

In The Last Decade

DE Stepan

9 papers receiving 477 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
DE Stepan	314	149	145	113	93	9	503
I. Khouri	347 1.1×	86 0.6×	162 1.1×	122 1.1×	71 0.8×	13	455
Bachra Choufi	279 0.9×	103 0.7×	138 1.0×	118 1.0×	120 1.3×	24	467
Ž Pavletić	354 1.1×	68 0.5×	226 1.6×	152 1.3×	129 1.4×	22	563
Xavier Cahu	221 0.7×	109 0.7×	146 1.0×	80 0.7×	114 1.2×	22	414
Christian Duncker	247 0.8×	50 0.3×	129 0.9×	141 1.2×	49 0.5×	8	448
N J Chao	327 1.0×	94 0.6×	168 1.2×	99 0.9×	54 0.6×	18	491
M. Hoffknecht	270 0.9×	185 1.2×	174 1.2×	98 0.9×	117 1.3×	17	495
Lijda Vellekoop	231 0.7×	167 1.1×	149 1.0×	70 0.6×	78 0.8×	11	403
Eve‐Marie Neidhardt‐Berard	258 0.8×	172 1.2×	246 1.7×	95 0.8×	126 1.4×	11	482
PI Warkentin	589 1.9×	51 0.3×	201 1.4×	137 1.2×	139 1.5×	28	718

Countries citing papers authored by DE Stepan

Since Specialization

Citations

This map shows the geographic impact of DE Stepan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DE Stepan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DE Stepan more than expected).

Fields of papers citing papers by DE Stepan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DE Stepan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DE Stepan. The network helps show where DE Stepan may publish in the future.

Co-authorship network of co-authors of DE Stepan

This figure shows the co-authorship network connecting the top 25 collaborators of DE Stepan. A scholar is included among the top collaborators of DE Stepan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DE Stepan. DE Stepan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Fleming, WH, et al.. (2002). Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis. Bone Marrow Transplantation. 30(5). 279–285. 8 indexed citations

2.

Stein, Anthony S., Margaret O’Donnell, GM Schmidt, et al.. (1996). In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.. Journal of Clinical Oncology. 14(8). 2206–2216. 46 indexed citations

3.

Nademanee, Auayporn, GM Schmidt, PM Parker, et al.. (1995). The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood. 86(3). 1228–1234. 118 indexed citations

4.

Parker, PM, Nelson J. Chao, AP Nademanee, et al.. (1995). Thalidomide as salvage therapy for chronic graft-versus-host disease. Blood. 86(9). 3604–3609. 140 indexed citations

5.

Nademanee, Auayporn, GM Schmidt, Pablo Parker, et al.. (1995). The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone. Blood. 86(3). 1228–1234. 4 indexed citations

6.

Nademanee, Auayporn, MR O’Donnell, DS Snyder, et al.. (1995). High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors. Blood. 85(5). 1381–1390. 126 indexed citations

7.

LeBien, Tucker W., et al.. (1985). Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. Blood. 65(4). 945–950. 47 indexed citations

8.

LeBien, Tucker W., et al.. (1985). Utilization of a colony assay to assess the variables influencing elimination of leukemic cells from human bone marrow with monoclonal antibodies and complement. Blood. 65(4). 945–950. 3 indexed citations

9.

Stepan, DE, et al.. (1984). In vitro cytodestruction of human leukemic cells using murine monoclonal antibodies and human complement. Blood. 63(5). 1120–1124. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact